The transcatheter embolization and occlusion devices market will register a CAGR of almost 8% by 2023

Wednesday, April 17, 2019 Medical Gadgets
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, April 16, 2019 /PRNewswire/ -- About this marketThe high demand for non-coils embolization devices is one

of the critical reasons that will drive the transcatheter embolization and occlusion devices market. Non-coils embolization devices such as liquid embolic are preferred by surgeons as it support minimally invasive surgery. Flow diverting devices and
embolization particles are some of the non-coils embolization devices that prevents catheter entrapment complication and imprecise deployment rates. The rising adoption of these devices in academic and research institutes, ASC, hospitals, and diagnostic centers will further drive the growth of the transcatheter embolization and occlusion devices market during the forecast period. Analysts have predicted that the transcatheter embolization and occlusion devices market will register a CAGR of almost 8% by 2023.Read the full report: https://www.reportlinker.com/p05764048/?utm_source=PRN Market OverviewHigh demand for non-coils embolization devicesOne of the growth drivers of the global transcatheter embolization and occlusion devices market is the high demand for non-coils embolization devices. The rising popularity of non-coils embolization devices among end-users such as hospitals will drive the growth of the global transcatheter embolization and occlusion devices market during the forecast period.Increasing number of product recallsOne of the challenges in the growth of the global transcatheter embolization and occlusion devices market is the increasing number of product recalls. This will slow down the launch of products in the market, which affects the sales and revenues of vendors.For the detailed list of factors that will drive and challenge the growth of the transcatheter embolization and occlusion devices market during 2019-2023, view our report.Competitive LandscapeThe market appears to be moderately fragmented and with the presence of several market players. Several vendors in the market are focusing on radioembolization or selective internal radiation therapy (SIRT) technology for treating patients with advanced cancer stages. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.Read the full report: https://www.reportlinker.com/p05764048/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place. __________________________ Contact Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001

Cision View original content:http://www.prnewswire.com/news-releases/the-transcatheter-embolization-and-occlusion-devices-market-will-register-a-cagr-of-almost-8-by-2023-300833313.html

SOURCE Reportlinker



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store